For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication Ozempic led to permanent vision loss. Elizabeth Pennell alleges that Novo ...